Monday - January 26, 2026

Category Archives: Pharmaceuticals & Biotech

Irritable Bowel Syndrome Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | CinRx Pharma, Octavian Therapeutics, P4 Microbiome, Biomica, Invea Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Irritable Bowel Syndrome pipeline constitutes 15+ key companies continuously working towards developing 20+ Irritable Bowel Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Parkinson’s Disease Market Statistics Expected to Experience Major Growth by 2034, According to DelveInsight | FAScinate Therapeutics, Roche, Pharma Two B Ltd., Neuropore Therapies, Olatec Therapeutic

The Key Parkinson’s Disease Companies in the market include – FAScinate Therapeutics, Hoffmann-La Roche, Pharma Two B Ltd., Neuropore Therapies, Inc., Olatec Therapeutics, UCB Biopharma, Vaxxinity, Modag, Peptron, Kissei Pharmaceutical, Cerevel Therapeutics, and others.   DelveInsight’s “Parkinson’s Disease Market Insights, … Continue reading →

Car T Cell Therapy For Multiple Myeloma Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Car T Cell Therapy For Multiple Myeloma pipeline constitutes 5+ key companies continuously working towards developing 5+ Car T Cell Therapy For Multiple Myeloma treatment therapies, analysis of Clinical Trials, … Continue reading →

Pancreatic Cancer Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd

The Key Pancreatic Cancer Companies in the market include – AstraZeneca, Merck Sharp & Dohme, Actuate Therapeutics, Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co.Ltd, Carisma Therapeutics Inc, Cue Biopharma, Bold Therapeutics, Purple Biotech Ltd, ENB Therapeutics, … Continue reading →

American Lithium Minerals (OTC: AMLM) Accelerates Global Expansion Across Gold, Silver, Copper, Critical Minerals, and Rare Earth Elements

American Lithium Minerals (OTCID: AMLM) continues to reposition itself as a diversified, U.S.-anchored critical minerals company as it advances a series of mineral acquisitions spanning North America, South America, and Africa. The Company’s strategy aligns with growing U.S. government and … Continue reading →

Chronic Urticaria Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Chronic Urticaria Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Chronic Urticaria pipeline landscape. It covers the Chronic Urticaria pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Chlorinated Paraffins (CPs): Applications in Plastics, Rubber, Lubricants & Environmental Guide

Chlorinated paraffins (CPs) are chlorinated derivatives of paraffin hydrocarbons. Their properties vary with chlorine content, and they are characterized by low volatility, flame retardancy, electrical insulation, and low cost. They play essential roles in industry as plasticizers, flame retardants, lubricants, … Continue reading →

Sickle Cell Disease Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics, Graphite Bio, Roche

The Key Sickle Cell Disease Companies in the market include – BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharmaceuticals, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis Pharma, Editas Medicin, Pfizer, Emmaus Medical, Inc, Vertex Pharmaceuticals, CRISPR therapeutics, Bluebird Bio, Pfizer, Novo … Continue reading →